Global and United States Rheumatology Drugs Market Size, Status and Forecast 2020-2026
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Rheumatology Drugs Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 Disease Modifying Anti-rheumatic Drugs
1.2.3 Nonsteroidal Anti-inflammatory Drugs
1.2.4 Corticosteroids
1.2.5 Uric Acid Drugs
1.2.6 Others
1.3 Market by Application
1.3.1 Global Rheumatology Drugs Market Share by Application: 2020 VS 2026
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Rheumatology Drugs Market Perspective (2015-2026)
2.2 Global Rheumatology Drugs Growth Trends by Regions
2.2.1 Rheumatology Drugs Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Rheumatology Drugs Historic Market Share by Regions (2015-2020)
2.2.3 Rheumatology Drugs Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Rheumatology Drugs Players by Market Size
3.1.1 Global Top Rheumatology Drugs Players by Revenue (2015-2020)
3.1.2 Global Rheumatology Drugs Revenue Market Share by Players (2015-2020)
3.2 Global Rheumatology Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Rheumatology Drugs Revenue
3.4 Global Rheumatology Drugs Market Concentration Ratio
3.4.1 Global Rheumatology Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Rheumatology Drugs Revenue in 2019
3.5 Key Players Rheumatology Drugs Area Served
3.6 Key Players Rheumatology Drugs Product Solution and Service
3.7 Date of Enter into Rheumatology Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Rheumatology Drugs Breakdown Data by Type (2015-2026)
4.1 Global Rheumatology Drugs Historic Market Size by Type (2015-2020)
4.2 Global Rheumatology Drugs Forecasted Market Size by Type (2021-2026)
5 Rheumatology Drugs Breakdown Data by Application (2015-2026)
5.1 Global Rheumatology Drugs Historic Market Size by Application (2015-2020)
5.2 Global Rheumatology Drugs Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Rheumatology Drugs Market Size (2015-2026)
6.2 North America Rheumatology Drugs Market Size by Type (2015-2020)
6.3 North America Rheumatology Drugs Market Size by Application (2015-2020)
6.4 North America Rheumatology Drugs Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Rheumatology Drugs Market Size (2015-2026)
7.2 Europe Rheumatology Drugs Market Size by Type (2015-2020)
7.3 Europe Rheumatology Drugs Market Size by Application (2015-2020)
7.4 Europe Rheumatology Drugs Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe
8 China
8.1 China Rheumatology Drugs Market Size (2015-2026)
8.2 China Rheumatology Drugs Market Size by Type (2015-2020)
8.3 China Rheumatology Drugs Market Size by Application (2015-2020)
8.4 China Rheumatology Drugs Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific
9 Japan
9.1 Japan Rheumatology Drugs Market Size (2015-2026)
9.2 Japan Rheumatology Drugs Market Size by Type (2015-2020)
9.3 Japan Rheumatology Drugs Market Size by Application (2015-2020)
9.4 Japan Rheumatology Drugs Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Southeast Asia
10.1 Southeast Asia Rheumatology Drugs Market Size (2015-2026)
10.2 Southeast Asia Rheumatology Drugs Market Size by Type (2015-2020)
10.3 Southeast Asia Rheumatology Drugs Market Size by Application (2015-2020)
10.4 Southeast Asia Rheumatology Drugs Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa
11 Key Players Profiles
11.1 Takeda Pharmaceutical
11.1.1 Takeda Pharmaceutical Company Details
11.1.2 Takeda Pharmaceutical Business Overview
11.1.3 Takeda Pharmaceutical Rheumatology Drugs Introduction
11.1.4 Takeda Pharmaceutical Revenue in Rheumatology Drugs Business (2015-2020))
11.1.5 Takeda Pharmaceutical Recent Development
11.2 Sanofi
11.2.1 Sanofi Company Details
11.2.2 Sanofi Business Overview
11.2.3 Sanofi Rheumatology Drugs Introduction
11.2.4 Sanofi Revenue in Rheumatology Drugs Business (2015-2020)
11.2.5 Sanofi Recent Development
11.3 Genentech
11.3.1 Genentech Company Details
11.3.2 Genentech Business Overview
11.3.3 Genentech Rheumatology Drugs Introduction
11.3.4 Genentech Revenue in Rheumatology Drugs Business (2015-2020)
11.3.5 Genentech Recent Development
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Rheumatology Drugs Introduction
11.4.4 Novartis Revenue in Rheumatology Drugs Business (2015-2020)
11.4.5 Novartis Recent Development
11.5 Janssen Biotech
11.5.1 Janssen Biotech Company Details
11.5.2 Janssen Biotech Business Overview
11.5.3 Janssen Biotech Rheumatology Drugs Introduction
11.5.4 Janssen Biotech Revenue in Rheumatology Drugs Business (2015-2020)
11.5.5 Janssen Biotech Recent Development
11.6 Amgen
11.6.1 Amgen Company Details
11.6.2 Amgen Business Overview
11.6.3 Amgen Rheumatology Drugs Introduction
11.6.4 Amgen Revenue in Rheumatology Drugs Business (2015-2020)
11.6.5 Amgen Recent Development
11.7 AbbVie
11.7.1 AbbVie Company Details
11.7.2 AbbVie Business Overview
11.7.3 AbbVie Rheumatology Drugs Introduction
11.7.4 AbbVie Revenue in Rheumatology Drugs Business (2015-2020)
11.7.5 AbbVie Recent Development
11.8 Pfizer
11.8.1 Pfizer Company Details
11.8.2 Pfizer Business Overview
11.8.3 Pfizer Rheumatology Drugs Introduction
11.8.4 Pfizer Revenue in Rheumatology Drugs Business (2015-2020)
11.8.5 Pfizer Recent Development
11.9 Bristol-Myers Squibb Company
11.9.1 Bristol-Myers Squibb Company Company Details
11.9.2 Bristol-Myers Squibb Company Business Overview
11.9.3 Bristol-Myers Squibb Company Rheumatology Drugs Introduction
11.9.4 Bristol-Myers Squibb Company Revenue in Rheumatology Drugs Business (2015-2020)
11.9.5 Bristol-Myers Squibb Company Recent Development
11.10 Merck & Co.
11.10.1 Merck & Co. Company Details
11.10.2 Merck & Co. Business Overview
11.10.3 Merck & Co. Rheumatology Drugs Introduction
11.10.4 Merck & Co. Revenue in Rheumatology Drugs Business (2015-2020)
11.10.5 Merck & Co. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesTable 1. Global Rheumatology Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 3. Key Players of Disease Modifying Anti-rheumatic Drugs
Table 4. Key Players of Nonsteroidal Anti-inflammatory Drugs
Table 5. Key Players of Corticosteroids
Table 6. Key Players of Uric Acid Drugs
Table 7. Key Players of Others
Table 8. Global Rheumatology Drugs Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Rheumatology Drugs Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Rheumatology Drugs Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Rheumatology Drugs Market Share by Regions (2015-2020)
Table 12. Global Rheumatology Drugs Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Rheumatology Drugs Market Share by Regions (2021-2026)
Table 14. Rheumatology Drugs Market Market Trends
Table 15. Rheumatology Drugs Market Drivers
Table 16. Rheumatology Drugs Market Challenges
Table 17. Rheumatology Drugs Market Restraints
Table 18. Global Rheumatology Drugs Revenue by Players (2015-2020) (US$ Million)
Table 19. Global Rheumatology Drugs Market Share by Players (2015-2020)
Table 20. Global Top Rheumatology Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Rheumatology Drugs as of 2019)
Table 21. Global Rheumatology Drugs by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Rheumatology Drugs Product Solution and Service
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Rheumatology Drugs Market Size by Type (2015-2020) (US$ Million)
Table 26. Global Rheumatology Drugs Market Size Share by Type (2015-2020)
Table 27. Global Rheumatology Drugs Revenue Market Share by Type (2021-2026)
Table 28. Global Rheumatology Drugs Market Size Share by Application (2015-2020)
Table 29. Global Rheumatology Drugs Market Size by Application (2015-2020) (US$ Million)
Table 30. Global Rheumatology Drugs Market Size Share by Application (2021-2026)
Table 31. North America Rheumatology Drugs Market Size by Type (2015-2020) (US$ Million)
Table 32. North America Rheumatology Drugs Market Share by Type (2015-2020)
Table 33. North America Rheumatology Drugs Market Size by Application (2015-2020) (US$ Million)
Table 34. North America Rheumatology Drugs Market Share by Application (2015-2020)
Table 35. North America Rheumatology Drugs Market Size by Country (US$ Million) (2015-2020)
Table 36. North America Rheumatology Drugs Market Share by Country (2015-2020)
Table 37. Europe Rheumatology Drugs Market Size by Type (2015-2020) (US$ Million)
Table 38. Europe Rheumatology Drugs Market Share by Type (2015-2020)
Table 39. Europe Rheumatology Drugs Market Size by Application (2015-2020) (US$ Million)
Table 40. Europe Rheumatology Drugs Market Share by Application (2015-2020)
Table 41. Europe Rheumatology Drugs Market Size by Country (US$ Million) (2015-2020)
Table 42. Europe Rheumatology Drugs Market Share by Country (2015-2020)
Table 43. China Rheumatology Drugs Market Size by Type (2015-2020) (US$ Million)
Table 44. China Rheumatology Drugs Market Share by Type (2015-2020)
Table 45. China Rheumatology Drugs Market Size by Application (2015-2020) (US$ Million)
Table 46. China Rheumatology Drugs Market Share by Application (2015-2020)
Table 47. China Rheumatology Drugs Market Size by Region (US$ Million) (2015-2020)
Table 48. China Rheumatology Drugs Market Share by Region (2015-2020)
Table 49. Japan Rheumatology Drugs Market Size by Type (2015-2020) (US$ Million)
Table 50. Japan Rheumatology Drugs Market Share by Type (2015-2020)
Table 51. Japan Rheumatology Drugs Market Size by Application (2015-2020) (US$ Million)
Table 52. Japan Rheumatology Drugs Market Share by Application (2015-2020)
Table 53. Japan Rheumatology Drugs Market Size by Country (US$ Million) (2015-2020)
Table 54. Japan Rheumatology Drugs Market Share by Country (2015-2020)
Table 55. Southeast Asia Rheumatology Drugs Market Size by Type (2015-2020) (US$ Million)
Table 56. Southeast Asia Rheumatology Drugs Market Share by Type (2015-2020)
Table 57. Southeast Asia Rheumatology Drugs Market Size by Application (2015-2020) (US$ Million)
Table 58. Southeast Asia Rheumatology Drugs Market Share by Application (2015-2020)
Table 59. Southeast Asia Rheumatology Drugs Market Size by Country (US$ Million) (2015-2020)
Table 60. Southeast Asia Rheumatology Drugs Market Share by Country (2015-2020)
Table 61. Takeda Pharmaceutical Company Details
Table 62. Takeda Pharmaceutical Business Overview
Table 63. Takeda Pharmaceutical Product
Table 64. Takeda Pharmaceutical Revenue in Rheumatology Drugs Business (2015-2020) (US$ Million)
Table 65. Takeda Pharmaceutical Recent Development
Table 66. Sanofi Company Details
Table 67. Sanofi Business Overview
Table 68. Sanofi Product
Table 69. Sanofi Revenue in Rheumatology Drugs Business (2015-2020) (US$ Million)
Table 70. Sanofi Recent Development
Table 71. Genentech Company Details
Table 72. Genentech Business Overview
Table 73. Genentech Product
Table 74. Genentech Revenue in Rheumatology Drugs Business (2015-2020) (US$ Million)
Table 75. Genentech Recent Development
Table 76. Novartis Company Details
Table 77. Novartis Business Overview
Table 78. Novartis Product
Table 79. Novartis Revenue in Rheumatology Drugs Business (2015-2020) (US$ Million)
Table 80. Novartis Recent Development
Table 81. Janssen Biotech Company Details
Table 82. Janssen Biotech Business Overview
Table 83. Janssen Biotech Product
Table 84. Janssen Biotech Revenue in Rheumatology Drugs Business (2015-2020) (US$ Million)
Table 85. Janssen Biotech Recent Development
Table 86. Amgen Company Details
Table 87. Amgen Business Overview
Table 88. Amgen Product
Table 89. Amgen Revenue in Rheumatology Drugs Business (2015-2020) (US$ Million)
Table 90. Amgen Recent Development
Table 91. AbbVie Company Details
Table 92. AbbVie Business Overview
Table 93. AbbVie Product
Table 94. AbbVie Revenue in Rheumatology Drugs Business (2015-2020) (US$ Million)
Table 95. AbbVie Recent Development
Table 96. Pfizer Business Overview
Table 97. Pfizer Product
Table 98. Pfizer Company Details
Table 99. Pfizer Revenue in Rheumatology Drugs Business (2015-2020) (US$ Million)
Table 100. Pfizer Recent Development
Table 101. Bristol-Myers Squibb Company Company Details
Table 102. Bristol-Myers Squibb Company Business Overview
Table 103. Bristol-Myers Squibb Company Product
Table 104. Bristol-Myers Squibb Company Revenue in Rheumatology Drugs Business (2015-2020) (US$ Million)
Table 105. Bristol-Myers Squibb Company Recent Development
Table 106. Merck & Co. Company Details
Table 107. Merck & Co. Business Overview
Table 108. Merck & Co. Product
Table 109. Merck & Co. Revenue in Rheumatology Drugs Business (2015-2020) (US$ Million)
Table 110. Merck & Co. Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of FiguresFigure 1. Global Rheumatology Drugs Market Share by Type: 2020 VS 2026
Figure 2. Disease Modifying Anti-rheumatic Drugs Features
Figure 3. Nonsteroidal Anti-inflammatory Drugs Features
Figure 4. Corticosteroids Features
Figure 5. Uric Acid Drugs Features
Figure 6. Others Features
Figure 7. Global Rheumatology Drugs Market Share by Application: 2020 VS 2026
Figure 8. Hospital Pharmacy Case Studies
Figure 9. Retail Pharmacy Case Studies
Figure 10. Online Pharmacy Case Studies
Figure 11. Rheumatology Drugs Report Years Considered
Figure 12. Global Rheumatology Drugs Market Size (US$ Million), YoY Growth 2015-2026
Figure 13. Global Rheumatology Drugs Market Share by Regions: 2020 VS 2026
Figure 14. Global Rheumatology Drugs Market Share by Regions (2021-2026)
Figure 15. Global Rheumatology Drugs Market Share by Players in 2019
Figure 16. Global Top Rheumatology Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Rheumatology Drugs as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Rheumatology Drugs Revenue in 2019
Figure 18. North America Rheumatology Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 19. United States Rheumatology Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 20. Canada Rheumatology Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 21. Europe Rheumatology Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 22. Germany Rheumatology Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 23. France Rheumatology Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 24. U.K. Rheumatology Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. Italy Rheumatology Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. Russia Rheumatology Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. Nordic Rheumatology Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. Rest of Europe Rheumatology Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. Asia-Pacific Rheumatology Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. China Rheumatology Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. Japan Rheumatology Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. South Korea Rheumatology Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. Southeast Asia Rheumatology Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. India Rheumatology Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. Australia Rheumatology Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. Rest of Asia-Pacific Rheumatology Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. Latin America Rheumatology Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. Mexico Rheumatology Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. Brazil Rheumatology Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. Middle East & Africa Rheumatology Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 41. Turkey Rheumatology Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 42. Saudi Arabia Rheumatology Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 43. UAE Rheumatology Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 44. Rest of Middle East & Africa Rheumatology Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 45. Takeda Pharmaceutical Revenue Growth Rate in Rheumatology Drugs Business (2015-2020)
Figure 46. Sanofi Revenue Growth Rate in Rheumatology Drugs Business (2015-2020)
Figure 47. Genentech Revenue Growth Rate in Rheumatology Drugs Business (2015-2020)
Figure 48. Novartis Revenue Growth Rate in Rheumatology Drugs Business (2015-2020)
Figure 49. Janssen Biotech Revenue Growth Rate in Rheumatology Drugs Business (2015-2020)
Figure 50. Amgen Revenue Growth Rate in Rheumatology Drugs Business (2015-2020)
Figure 51. AbbVie Revenue Growth Rate in Rheumatology Drugs Business (2015-2020)
Figure 52. Pfizer Revenue Growth Rate in Rheumatology Drugs Business (2015-2020)
Figure 53. Bristol-Myers Squibb Company Revenue Growth Rate in Rheumatology Drugs Business (2015-2020)
Figure 54. Merck & Co. Revenue Growth Rate in Rheumatology Drugs Business (2015-2020)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed